Strategy 2: Reformulation and New Delivery Systems Developing a new formulation of an existing compound extended-release versus immediate-release, a once-daily version versus a twice-daily version, a transdermal patch versus an oral tablet can generate new patent protection and potentially new regulatory exclusivities
They are usually injectable medications, with a liquid medication injected into the fatty tissue just under your skin
Both are driven by a strong urge to engage in repetitive behaviors, but the motivation and feeling of engaging in these behaviors is different
With in-depth testing, all the products are ensured to meet the guidelines of the WHO
Genetic and Environmental Triggers The exact cause of pernicious anemia is not known
Participants with a high genetic risk score (GRS) were over twice as likely to develop nausea when treated with liraglutide, a common GLP-1 medication, compared with those with a low GRS (68% vs 30%)
